APO Research
Talk to an analyst

APO RESEARCH · REPORT

Belladonna Tablets

Compare research editions
View pricing & licenses

Selected research

Industry Research

Belladonna Tablets Industry Research Report 2026

28 December 2025148 pages

Choose your research edition.

Industry ResearchBelladonna Tablets Industry Research Report 2026148 pages · $2,950 USDIndustry Growth & TrendsGlobal Belladonna Tablets Industry Growth and Trends Forecast to 2032125 pages · $3,450 USDMarket StructureGlobal Belladonna Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Belladonna Tablets Market Outlook and Growth Opportunities 2026215 pages · $4,250 USDMarket Analysis & ForecastGlobal Belladonna Tablets Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

The global Belladonna Tablets market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Belladonna Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Belladonna Tablets is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Belladonna Tablets is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Belladonna Tablets include Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd., Yangzhou Aidi Pharmaceutical Co., Ltd., Southwest Pharmaceutical Co., Ltd., Wanbangde Pharmaceutical Group Co., Ltd., CSPC Ouyi Pharmaceutical Co., Ltd., Shenyang Tonglian Pharmaceutical Co., Ltd., Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd., Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. and Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Belladonna Tablets market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Belladonna Tablets Market by Company

Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd.

Yangzhou Aidi Pharmaceutical Co., Ltd.

Southwest Pharmaceutical Co., Ltd.

Wanbangde Pharmaceutical Group Co., Ltd.

CSPC Ouyi Pharmaceutical Co., Ltd.

Shenyang Tonglian Pharmaceutical Co., Ltd.

Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd.

Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd.

Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd.

Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd.

Jilin Luwang Pharmaceutical Co., Ltd.

Jilin Hengjin Pharmaceutical Co., Ltd.

Jilin Daojun Pharmaceutical Co., Ltd.

Henan Baiquan Pharmaceutical Co., Ltd.

Sinopharm Xinjiang Pharmaceutical Co., Ltd.

Guangxi Dahaiguang Pharmaceutical Co., Ltd.

Gansu Lanyao Pharmaceutical Co., Ltd.

Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd.

Aimin Pharmaceutical Group Co., Ltd.

Weleda

Raritan Pharmaceuticals

Hyland's Inc

Belladonna Tablets Segment by Type

Compound Preparations

Single Preparations

Belladonna Tablets Segment by Application

Hospital

Clinic

Other

Belladonna Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Belladonna Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Belladonna Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Belladonna Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Belladonna Tablets manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Belladonna Tablets by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Belladonna Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Belladonna Tablets Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Belladonna Tablets Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Belladonna Tablets Sales Market Share by Manufacturers (2021-2026) Table 8. Global Belladonna Tablets Revenue of Manufacturers (2021-2026) Table 9. Global Belladonna Tablets Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Belladonna Tablets Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Belladonna Tablets Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Belladonna Tablets, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Belladonna Tablets, Product Type & Application Table 14. Global Belladonna Tablets Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Belladonna Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd. Company Information Table 19. Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd. Business Overview Table 20. Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd. Belladonna Tablets Product Portfolio Table 22. Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd. Recent Developments Table 23. Yangzhou Aidi Pharmaceutical Co., Ltd. Company Information Table 24. Yangzhou Aidi Pharmaceutical Co., Ltd. Business Overview Table 25. Yangzhou Aidi Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Yangzhou Aidi Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 27. Yangzhou Aidi Pharmaceutical Co., Ltd. Recent Developments Table 28. Southwest Pharmaceutical Co., Ltd. Company Information Table 29. Southwest Pharmaceutical Co., Ltd. Business Overview Table 30. Southwest Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Southwest Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 32. Southwest Pharmaceutical Co., Ltd. Recent Developments Table 33. Wanbangde Pharmaceutical Group Co., Ltd. Company Information Table 34. Wanbangde Pharmaceutical Group Co., Ltd. Business Overview Table 35. Wanbangde Pharmaceutical Group Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Wanbangde Pharmaceutical Group Co., Ltd. Belladonna Tablets Product Portfolio Table 37. Wanbangde Pharmaceutical Group Co., Ltd. Recent Developments Table 38. CSPC Ouyi Pharmaceutical Co., Ltd. Company Information Table 39. CSPC Ouyi Pharmaceutical Co., Ltd. Business Overview Table 40. CSPC Ouyi Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. CSPC Ouyi Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 42. CSPC Ouyi Pharmaceutical Co., Ltd. Recent Developments Table 43. Shenyang Tonglian Pharmaceutical Co., Ltd. Company Information Table 44. Shenyang Tonglian Pharmaceutical Co., Ltd. Business Overview Table 45. Shenyang Tonglian Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Shenyang Tonglian Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 47. Shenyang Tonglian Pharmaceutical Co., Ltd. Recent Developments Table 48. Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd. Company Information Table 49. Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd. Business Overview Table 50. Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 52. Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd. Recent Developments Table 53. Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Company Information Table 54. Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Business Overview Table 55. Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 57. Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Recent Developments Table 58. Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Company Information Table 59. Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Business Overview Table 60. Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 62. Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Recent Developments Table 63. Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. Company Information Table 64. Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. Business Overview Table 65. Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. Belladonna Tablets Product Portfolio Table 67. Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. Recent Developments Table 68. Jilin Luwang Pharmaceutical Co., Ltd. Company Information Table 69. Jilin Luwang Pharmaceutical Co., Ltd. Business Overview Table 70. Jilin Luwang Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Jilin Luwang Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 72. Jilin Luwang Pharmaceutical Co., Ltd. Recent Developments Table 73. Jilin Hengjin Pharmaceutical Co., Ltd. Company Information Table 74. Jilin Hengjin Pharmaceutical Co., Ltd. Business Overview Table 75. Jilin Hengjin Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Jilin Hengjin Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 77. Jilin Hengjin Pharmaceutical Co., Ltd. Recent Developments Table 78. Jilin Daojun Pharmaceutical Co., Ltd. Company Information Table 79. Jilin Daojun Pharmaceutical Co., Ltd. Business Overview Table 80. Jilin Daojun Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Jilin Daojun Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 82. Jilin Daojun Pharmaceutical Co., Ltd. Recent Developments Table 83. Henan Baiquan Pharmaceutical Co., Ltd. Company Information Table 84. Henan Baiquan Pharmaceutical Co., Ltd. Business Overview Table 85. Henan Baiquan Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Henan Baiquan Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 87. Henan Baiquan Pharmaceutical Co., Ltd. Recent Developments Table 88. Sinopharm Xinjiang Pharmaceutical Co., Ltd. Company Information Table 89. Sinopharm Xinjiang Pharmaceutical Co., Ltd. Business Overview Table 90. Sinopharm Xinjiang Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Sinopharm Xinjiang Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 92. Sinopharm Xinjiang Pharmaceutical Co., Ltd. Recent Developments Table 93. Guangxi Dahaiguang Pharmaceutical Co., Ltd. Company Information Table 94. Guangxi Dahaiguang Pharmaceutical Co., Ltd. Business Overview Table 95. Guangxi Dahaiguang Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Guangxi Dahaiguang Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 97. Guangxi Dahaiguang Pharmaceutical Co., Ltd. Recent Developments Table 98. Gansu Lanyao Pharmaceutical Co., Ltd. Company Information Table 99. Gansu Lanyao Pharmaceutical Co., Ltd. Business Overview Table 100. Gansu Lanyao Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Gansu Lanyao Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 102. Gansu Lanyao Pharmaceutical Co., Ltd. Recent Developments Table 103. Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Company Information Table 104. Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Business Overview Table 105. Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 107. Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Recent Developments Table 108. Aimin Pharmaceutical Group Co., Ltd. Company Information Table 109. Aimin Pharmaceutical Group Co., Ltd. Business Overview Table 110. Aimin Pharmaceutical Group Co., Ltd. Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Aimin Pharmaceutical Group Co., Ltd. Belladonna Tablets Product Portfolio Table 112. Aimin Pharmaceutical Group Co., Ltd. Recent Developments Table 113. Weleda Company Information Table 114. Weleda Business Overview Table 115. Weleda Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Weleda Belladonna Tablets Product Portfolio Table 117. Weleda Recent Developments Table 118. Raritan Pharmaceuticals Company Information Table 119. Raritan Pharmaceuticals Business Overview Table 120. Raritan Pharmaceuticals Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Raritan Pharmaceuticals Belladonna Tablets Product Portfolio Table 122. Raritan Pharmaceuticals Recent Developments Table 123. Hyland's Inc Company Information Table 124. Hyland's Inc Business Overview Table 125. Hyland's Inc Belladonna Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Hyland's Inc Belladonna Tablets Product Portfolio Table 127. Hyland's Inc Recent Developments Table 128. Global Belladonna Tablets Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 129. Global Belladonna Tablets Sales by Region (2021-2026) & (K Units) Table 130. Global Belladonna Tablets Sales Market Share by Region (2021-2026) Table 131. Global Belladonna Tablets Sales by Region (2027-2032) & (K Units) Table 132. Global Belladonna Tablets Sales Market Share by Region (2027-2032) Table 133. Global Belladonna Tablets Revenue by Region (2021-2026) & (US$ Million) Table 134. Global Belladonna Tablets Revenue Market Share by Region (2021-2026) Table 135. Global Belladonna Tablets Revenue by Region (2027-2032) & (US$ Million) Table 136. Global Belladonna Tablets Revenue Market Share by Region (2027-2032) Table 137. North America Belladonna Tablets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. North America Belladonna Tablets Sales by Country (2021-2026) & (K Units) Table 139. North America Belladonna Tablets Sales by Country (2027-2032) & (K Units) Table 140. North America Belladonna Tablets Revenue by Country (2021-2026) & (US$ Million) Table 141. North America Belladonna Tablets Revenue by Country (2027-2032) & (US$ Million) Table 142. Europe Belladonna Tablets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. Europe Belladonna Tablets Sales by Country (2021-2026) & (K Units) Table 144. Europe Belladonna Tablets Sales by Country (2027-2032) & (K Units) Table 145. Europe Belladonna Tablets Revenue by Country (2021-2026) & (US$ Million) Table 146. Europe Belladonna Tablets Revenue by Country (2027-2032) & (US$ Million) Table 147. Asia Pacific Belladonna Tablets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. Asia Pacific Belladonna Tablets Sales by Country (2021-2026) & (K Units) Table 149. Asia Pacific Belladonna Tablets Sales by Country (2027-2032) & (K Units) Table 150. Asia Pacific Belladonna Tablets Revenue by Country (2021-2026) & (US$ Million) Table 151. Asia Pacific Belladonna Tablets Revenue by Country (2027-2032) & (US$ Million) Table 152. South America Belladonna Tablets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 153. South America Belladonna Tablets Sales by Country (2021-2026) & (K Units) Table 154. South America Belladonna Tablets Sales by Country (2027-2032) & (K Units) Table 155. South America Belladonna Tablets Revenue by Country (2021-2026) & (US$ Million) Table 156. South America Belladonna Tablets Revenue by Country (2027-2032) & (US$ Million) Table 157. Middle East and Africa Belladonna Tablets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 158. Middle East and Africa Belladonna Tablets Sales by Country (2021-2026) & (K Units) Table 159. Middle East and Africa Belladonna Tablets Sales by Country (2027-2032) & (K Units) Table 160. Middle East and Africa Belladonna Tablets Revenue by Country (2021-2026) & (US$ Million) Table 161. Middle East and Africa Belladonna Tablets Revenue by Country (2027-2032) & (US$ Million) Table 162. Global Belladonna Tablets Sales by Type (2021-2026) & (K Units) Table 163. Global Belladonna Tablets Sales by Type (2027-2032) & (K Units) Table 164. Global Belladonna Tablets Sales Market Share by Type (2021-2026) Table 165. Global Belladonna Tablets Sales Market Share by Type (2027-2032) Table 166. Global Belladonna Tablets Revenue by Type (2021-2026) & (US$ Million) Table 167. Global Belladonna Tablets Revenue by Type (2027-2032) & (US$ Million) Table 168. Global Belladonna Tablets Revenue Market Share by Type (2021-2026) Table 169. Global Belladonna Tablets Revenue Market Share by Type (2027-2032) Table 170. Global Belladonna Tablets Price by Type (2021-2026) & (US$/Unit) Table 171. Global Belladonna Tablets Price by Type (2027-2032) & (US$/Unit) Table 172. Global Belladonna Tablets Sales by Application (2021-2026) & (K Units) Table 173. Global Belladonna Tablets Sales by Application (2027-2032) & (K Units) Table 174. Global Belladonna Tablets Sales Market Share by Application (2021-2026) Table 175. Global Belladonna Tablets Sales Market Share by Application (2027-2032) Table 176. Global Belladonna Tablets Revenue by Application (2021-2026) & (US$ Million) Table 177. Global Belladonna Tablets Revenue by Application (2027-2032) & (US$ Million) Table 178. Global Belladonna Tablets Revenue Market Share by Application (2021-2026) Table 179. Global Belladonna Tablets Revenue Market Share by Application (2027-2032) Table 180. Global Belladonna Tablets Price by Application (2021-2026) & (US$/Unit) Table 181. Global Belladonna Tablets Price by Application (2027-2032) & (US$/Unit) Table 182. Key Raw Materials Table 183. Raw Materials Key Suppliers Table 184. Belladonna Tablets Distributors List Table 185. Belladonna Tablets Customers List Table 186. Belladonna Tablets Industry Trends Table 187. Belladonna Tablets Industry Drivers Table 188. Belladonna Tablets Industry Restraints Table 189. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Belladonna Tablets Product Image Figure 5. Global Belladonna Tablets Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Belladonna Tablets Market Size (2021-2032) & (US$ Million) Figure 7. Global Belladonna Tablets Sales (2021-2032) & (K Units) Figure 8. Global Belladonna Tablets Average Price (US$/Unit) & (2021-2032) Figure 9. Compound Preparations Product Image Figure 10. Single Preparations Product Image Figure 11. Hospital Product Image Figure 12. Clinic Product Image Figure 13. Other Product Image Figure 14. Global Belladonna Tablets Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Belladonna Tablets, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Belladonna Tablets Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Belladonna Tablets Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Belladonna Tablets Sales by Region in 2025 Figure 20. Global Belladonna Tablets Revenue by Region in 2025 Figure 21. North America Belladonna Tablets Market Size by Country in 2025 Figure 22. North America Belladonna Tablets Sales Market Share by Country (2021-2032) Figure 23. North America Belladonna Tablets Revenue Market Share by Country (2021-2032) Figure 24. United States Belladonna Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Belladonna Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Belladonna Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Belladonna Tablets Market Size by Country in 2025 Figure 28. Europe Belladonna Tablets Sales Market Share by Country (2021-2032) Figure 29. Europe Belladonna Tablets Revenue Market Share by Country (2021-2032) Figure 30. Germany Belladonna Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Belladonna Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Belladonna Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Belladonna Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Belladonna Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Belladonna Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Belladonna Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Belladonna Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Belladonna Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Belladonna Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Belladonna Tablets Market Size by Country in 2025 Figure 41. Asia Pacific Belladonna Tablets Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Belladonna Tablets Revenue Market Share by Country (2021-2032) Figure 43. China Belladonna Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Belladonna Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Belladonna Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Belladonna Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Belladonna Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Belladonna Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Belladonna Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Belladonna Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Belladonna Tablets Market Size by Country in 2025 Figure 52. South America Belladonna Tablets Sales Market Share by Country (2021-2032) Figure 53. South America Belladonna Tablets Revenue Market Share by Country (2021-2032) Figure 54. Brazil Belladonna Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Belladonna Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Belladonna Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Belladonna Tablets Market Size by Country in 2025 Figure 58. Middle East and Africa Belladonna Tablets Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Belladonna Tablets Revenue Market Share by Country (2021-2032) Figure 60. Egypt Belladonna Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. South Africa Belladonna Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Israel Belladonna Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Türkiye Belladonna Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. GCC Countries Belladonna Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Global Belladonna Tablets Sales Market Share by Type (2021-2032) Figure 66. Global Belladonna Tablets Revenue Market Share by Type (2021-2032) Figure 67. Global Belladonna Tablets Price (US$/Unit) by Type (2021-2032) Figure 68. Global Belladonna Tablets Sales Market Share by Application (2021-2032) Figure 69. Global Belladonna Tablets Revenue Market Share by Application (2021-2032) Figure 70. Global Belladonna Tablets Price (US$/Unit) by Application (2021-2032) Figure 71. Belladonna Tablets Value Chain Figure 72. Belladonna Tablets Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Belladonna Tablets Industry Opportunities and Challenges

Scope & coverage.

Types
  • Compound Preparations
  • Single Preparations
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd.
  • Yangzhou Aidi Pharmaceutical Co., Ltd.
  • Southwest Pharmaceutical Co., Ltd.
  • Wanbangde Pharmaceutical Group Co., Ltd.
  • CSPC Ouyi Pharmaceutical Co., Ltd.
  • Shenyang Tonglian Pharmaceutical Co., Ltd.
  • Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd.
  • Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd.
  • Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd.
  • Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd.
  • Jilin Luwang Pharmaceutical Co., Ltd.
  • Jilin Hengjin Pharmaceutical Co., Ltd.
  • Jilin Daojun Pharmaceutical Co., Ltd.
  • Henan Baiquan Pharmaceutical Co., Ltd.
  • Sinopharm Xinjiang Pharmaceutical Co., Ltd.
  • Guangxi Dahaiguang Pharmaceutical Co., Ltd.
  • Gansu Lanyao Pharmaceutical Co., Ltd.
  • Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd.
  • Aimin Pharmaceutical Group Co., Ltd.
  • Weleda
  • Raritan Pharmaceuticals
  • Hyland's Inc

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Belladonna Tablets Market Size (2021-2032)
  4. 2.2.2 Global Belladonna Tablets Sales (2021-2032)
  5. 2.2.3 Global Belladonna Tablets Market Average Price (2021-2032)
  6. 2.3 Belladonna Tablets by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Compound Preparations
  9. 2.3.3 Single Preparations
  10. 2.4 Belladonna Tablets by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Hospital
  13. 2.4.3 Clinic
  14. 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Belladonna Tablets Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Belladonna Tablets Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Belladonna Tablets Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Belladonna Tablets Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Belladonna Tablets Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Belladonna Tablets, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Belladonna Tablets, Product Type & Application
  8. 3.8 Global Manufacturers of Belladonna Tablets, Established Date
  9. 3.9 Global Belladonna Tablets Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd.
  2. 4.1.1 Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd. Company Information
  3. 4.1.2 Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd. Business Overview
  4. 4.1.3 Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd. Belladonna Tablets Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd. Belladonna Tablets Product Portfolio
  6. 4.1.5 Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd. Recent Developments
  7. 4.2 Yangzhou Aidi Pharmaceutical Co., Ltd.
  8. 4.2.1 Yangzhou Aidi Pharmaceutical Co., Ltd. Company Information
  9. 4.2.2 Yangzhou Aidi Pharmaceutical Co., Ltd. Business Overview
  10. 4.2.3 Yangzhou Aidi Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Yangzhou Aidi Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  12. 4.2.5 Yangzhou Aidi Pharmaceutical Co., Ltd. Recent Developments
  13. 4.3 Southwest Pharmaceutical Co., Ltd.
  14. 4.3.1 Southwest Pharmaceutical Co., Ltd. Company Information
  15. 4.3.2 Southwest Pharmaceutical Co., Ltd. Business Overview
  16. 4.3.3 Southwest Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Southwest Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  18. 4.3.5 Southwest Pharmaceutical Co., Ltd. Recent Developments
  19. 4.4 Wanbangde Pharmaceutical Group Co., Ltd.
  20. 4.4.1 Wanbangde Pharmaceutical Group Co., Ltd. Company Information
  21. 4.4.2 Wanbangde Pharmaceutical Group Co., Ltd. Business Overview
  22. 4.4.3 Wanbangde Pharmaceutical Group Co., Ltd. Belladonna Tablets Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Wanbangde Pharmaceutical Group Co., Ltd. Belladonna Tablets Product Portfolio
  24. 4.4.5 Wanbangde Pharmaceutical Group Co., Ltd. Recent Developments
  25. 4.5 CSPC Ouyi Pharmaceutical Co., Ltd.
  26. 4.5.1 CSPC Ouyi Pharmaceutical Co., Ltd. Company Information
  27. 4.5.2 CSPC Ouyi Pharmaceutical Co., Ltd. Business Overview
  28. 4.5.3 CSPC Ouyi Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 CSPC Ouyi Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  30. 4.5.5 CSPC Ouyi Pharmaceutical Co., Ltd. Recent Developments
  31. 4.6 Shenyang Tonglian Pharmaceutical Co., Ltd.
  32. 4.6.1 Shenyang Tonglian Pharmaceutical Co., Ltd. Company Information
  33. 4.6.2 Shenyang Tonglian Pharmaceutical Co., Ltd. Business Overview
  34. 4.6.3 Shenyang Tonglian Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Shenyang Tonglian Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  36. 4.6.5 Shenyang Tonglian Pharmaceutical Co., Ltd. Recent Developments
  37. 4.7 Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd.
  38. 4.7.1 Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd. Company Information
  39. 4.7.2 Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd. Business Overview
  40. 4.7.3 Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  42. 4.7.5 Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd. Recent Developments
  43. 4.8 Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd.
  44. 4.8.1 Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Company Information
  45. 4.8.2 Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Business Overview
  46. 4.8.3 Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  48. 4.8.5 Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Recent Developments
  49. 4.9 Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd.
  50. 4.9.1 Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Company Information
  51. 4.9.2 Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Business Overview
  52. 4.9.3 Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Belladonna Tablets Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  54. 4.9.5 Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Recent Developments
  55. 4.10 Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd.
  56. 4.10.1 Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. Company Information
  57. 4.10.2 Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. Business Overview
  58. 4.10.3 Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. Belladonna Tablets Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. Belladonna Tablets Product Portfolio
  60. 4.10.5 Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. Recent Developments
  61. 4.11 Jilin Luwang Pharmaceutical Co., Ltd.
  62. 4.11.1 Jilin Luwang Pharmaceutical Co., Ltd. Company Information
  63. 4.11.2 Jilin Luwang Pharmaceutical Co., Ltd. Business Overview
  64. 4.11.3 Jilin Luwang Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Jilin Luwang Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  66. 4.11.5 Jilin Luwang Pharmaceutical Co., Ltd. Recent Developments
  67. 4.12 Jilin Hengjin Pharmaceutical Co., Ltd.
  68. 4.12.1 Jilin Hengjin Pharmaceutical Co., Ltd. Company Information
  69. 4.12.2 Jilin Hengjin Pharmaceutical Co., Ltd. Business Overview
  70. 4.12.3 Jilin Hengjin Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Jilin Hengjin Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  72. 4.12.5 Jilin Hengjin Pharmaceutical Co., Ltd. Recent Developments
  73. 4.13 Jilin Daojun Pharmaceutical Co., Ltd.
  74. 4.13.1 Jilin Daojun Pharmaceutical Co., Ltd. Company Information
  75. 4.13.2 Jilin Daojun Pharmaceutical Co., Ltd. Business Overview
  76. 4.13.3 Jilin Daojun Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Jilin Daojun Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  78. 4.13.5 Jilin Daojun Pharmaceutical Co., Ltd. Recent Developments
  79. 4.14 Henan Baiquan Pharmaceutical Co., Ltd.
  80. 4.14.1 Henan Baiquan Pharmaceutical Co., Ltd. Company Information
  81. 4.14.2 Henan Baiquan Pharmaceutical Co., Ltd. Business Overview
  82. 4.14.3 Henan Baiquan Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Henan Baiquan Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  84. 4.14.5 Henan Baiquan Pharmaceutical Co., Ltd. Recent Developments
  85. 4.15 Sinopharm Xinjiang Pharmaceutical Co., Ltd.
  86. 4.15.1 Sinopharm Xinjiang Pharmaceutical Co., Ltd. Company Information
  87. 4.15.2 Sinopharm Xinjiang Pharmaceutical Co., Ltd. Business Overview
  88. 4.15.3 Sinopharm Xinjiang Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Sinopharm Xinjiang Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  90. 4.15.5 Sinopharm Xinjiang Pharmaceutical Co., Ltd. Recent Developments
  91. 4.16 Guangxi Dahaiguang Pharmaceutical Co., Ltd.
  92. 4.16.1 Guangxi Dahaiguang Pharmaceutical Co., Ltd. Company Information
  93. 4.16.2 Guangxi Dahaiguang Pharmaceutical Co., Ltd. Business Overview
  94. 4.16.3 Guangxi Dahaiguang Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Guangxi Dahaiguang Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  96. 4.16.5 Guangxi Dahaiguang Pharmaceutical Co., Ltd. Recent Developments
  97. 4.17 Gansu Lanyao Pharmaceutical Co., Ltd.
  98. 4.17.1 Gansu Lanyao Pharmaceutical Co., Ltd. Company Information
  99. 4.17.2 Gansu Lanyao Pharmaceutical Co., Ltd. Business Overview
  100. 4.17.3 Gansu Lanyao Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Gansu Lanyao Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  102. 4.17.5 Gansu Lanyao Pharmaceutical Co., Ltd. Recent Developments
  103. 4.18 Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd.
  104. 4.18.1 Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Company Information
  105. 4.18.2 Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Business Overview
  106. 4.18.3 Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  108. 4.18.5 Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Recent Developments
  109. 4.19 Aimin Pharmaceutical Group Co., Ltd.
  110. 4.19.1 Aimin Pharmaceutical Group Co., Ltd. Company Information
  111. 4.19.2 Aimin Pharmaceutical Group Co., Ltd. Business Overview
  112. 4.19.3 Aimin Pharmaceutical Group Co., Ltd. Belladonna Tablets Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Aimin Pharmaceutical Group Co., Ltd. Belladonna Tablets Product Portfolio
  114. 4.19.5 Aimin Pharmaceutical Group Co., Ltd. Recent Developments
  115. 4.20 Weleda
  116. 4.20.1 Weleda Company Information
  117. 4.20.2 Weleda Business Overview
  118. 4.20.3 Weleda Belladonna Tablets Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Weleda Belladonna Tablets Product Portfolio
  120. 4.20.5 Weleda Recent Developments
  121. 4.21 Raritan Pharmaceuticals
  122. 4.21.1 Raritan Pharmaceuticals Company Information
  123. 4.21.2 Raritan Pharmaceuticals Business Overview
  124. 4.21.3 Raritan Pharmaceuticals Belladonna Tablets Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 Raritan Pharmaceuticals Belladonna Tablets Product Portfolio
  126. 4.21.5 Raritan Pharmaceuticals Recent Developments
  127. 4.22 Hyland's Inc
  128. 4.22.1 Hyland's Inc Company Information
  129. 4.22.2 Hyland's Inc Business Overview
  130. 4.22.3 Hyland's Inc Belladonna Tablets Sales, Revenue and Gross Margin (2021-2026)
  131. 4.22.4 Hyland's Inc Belladonna Tablets Product Portfolio
  132. 4.22.5 Hyland's Inc Recent Developments
5 Global Belladonna Tablets Market Scenario by Region
  1. 5.1 Global Belladonna Tablets Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Belladonna Tablets Sales by Region: 2021-2032
  3. 5.2.1 Global Belladonna Tablets Sales by Region: 2021-2026
  4. 5.2.2 Global Belladonna Tablets Sales by Region: 2027-2032
  5. 5.3 Global Belladonna Tablets Revenue by Region: 2021-2032
  6. 5.3.1 Global Belladonna Tablets Revenue by Region: 2021-2026
  7. 5.3.2 Global Belladonna Tablets Revenue by Region: 2027-2032
  8. 5.4 North America Belladonna Tablets Market Facts & Figures by Country
  9. 5.4.1 North America Belladonna Tablets Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Belladonna Tablets Sales by Country (2021-2032)
  11. 5.4.3 North America Belladonna Tablets Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Belladonna Tablets Market Facts & Figures by Country
  16. 5.5.1 Europe Belladonna Tablets Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Belladonna Tablets Sales by Country (2021-2032)
  18. 5.5.3 Europe Belladonna Tablets Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Belladonna Tablets Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Belladonna Tablets Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Belladonna Tablets Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Belladonna Tablets Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Belladonna Tablets Market Facts & Figures by Country
  41. 5.7.1 South America Belladonna Tablets Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Belladonna Tablets Sales by Country (2021-2032)
  43. 5.7.3 South America Belladonna Tablets Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Belladonna Tablets Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Belladonna Tablets Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Belladonna Tablets Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Belladonna Tablets Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Belladonna Tablets Sales by Type (2021-2032)
  2. 6.1.1 Global Belladonna Tablets Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Belladonna Tablets Sales Market Share by Type (2021-2032)
  4. 6.2 Global Belladonna Tablets Revenue by Type (2021-2032)
  5. 6.2.1 Global Belladonna Tablets Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Belladonna Tablets Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Belladonna Tablets Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Belladonna Tablets Sales by Application (2021-2032)
  2. 7.1.1 Global Belladonna Tablets Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Belladonna Tablets Sales Market Share by Application (2021-2032)
  4. 7.2 Global Belladonna Tablets Revenue by Application (2021-2032)
  5. 7.2.1 Global Belladonna Tablets Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Belladonna Tablets Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Belladonna Tablets Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Belladonna Tablets Value Chain Analysis
  2. 8.1.1 Belladonna Tablets Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Belladonna Tablets Production Mode & Process
  5. 8.2 Belladonna Tablets Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Belladonna Tablets Distributors
  8. 8.2.3 Belladonna Tablets Customers
9 Global Belladonna Tablets Analyzing Market Dynamics
  1. 9.1 Belladonna Tablets Industry Trends
  2. 9.2 Belladonna Tablets Industry Drivers
  3. 9.3 Belladonna Tablets Industry Opportunities and Challenges
  4. 9.4 Belladonna Tablets Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst